This webinar was recorded in March 2018.

Webinar Objectives

  • Review the prevalence/economic impact of allergic rhinitis (AR), also known as nasal allergies or hay fever
  • Define what is meant by difficult-to-manage Allergic Rhinitis
  • Recognize that optimal AR control is currently not being achieved in many patients
  • Discuss the impact of difficult-to-manage AR on quality of life and comorbidities
  • Discuss the need for shared decision making for immunotherapy options


Dr. Don Buckstein